title: Left ventricular restoration: how important is the surgical treatment of ischemic heart failure trial?
abstract: If the Surgical Treatment of Ischemic Heart Failure (STICH) trial demonstrates that surgical therapy is superior to medical therapy, early aggressive evaluation of coronary artery disease as a potentially correctable cause of new-onset heart failure would be the preferred strategy. This strategy could tremendously change the treatment of ischemic heart disease. Confirming the STICH revascularization hypothesis will dramatically increase the use of coronary artery bypass grafting among the millions of patients now being medically treated without evaluation for an ischemic cause.
authors.affiliation: San Donato Hospital, San Donato Milanese, Milano, Italy. menicanti@libero.it <menicanti@libero.it>
authors.forename: Lorenzo
authors.initials: L
authors.lastname: Menicanti
authors.forename: Marisa
authors.initials: M
authors.lastname: Di Donato
mesh_terms: D019317:Evidence-Based Medicine; D006801:Humans; D008944:Mitral Valve Insufficiency / Q000209:etiology / Q000503:physiopathology / Q000601:surgery; D017202:Myocardial Ischemia / Q000150:complications* / Q000503:physiopathology / Q000601:surgery*; D016896:Treatment Outcome; D018487:Ventricular Dysfunction, Left / Q000209:etiology* / Q000503:physiopathology / Q000601:surgery*; D020257:Ventricular Remodeling